M Portier

1.6k total citations · 1 hit paper
13 papers, 1.3k citations indexed

About

M Portier is a scholar working on Hematology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, M Portier has authored 13 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in M Portier's work include Multiple Myeloma Research and Treatments (6 papers), Neuroscience and Neuropharmacology Research (2 papers) and Cannabis and Cannabinoid Research (2 papers). M Portier is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Neuroscience and Neuropharmacology Research (2 papers) and Cannabis and Cannabinoid Research (2 papers). M Portier collaborates with scholars based in France and Australia. M Portier's co-authors include Pierre Casellas, M Rinaldi-Carmona, Bernard Calandra, Francis Barth, Régis Bataille, Jean‐Marie Derocq, Monsif Bouaboula, Gérard Le Fur, J. C. Brelière and Christian Congy and has published in prestigious journals such as Blood, The Journal of Immunology and Scientific Reports.

In The Last Decade

M Portier

13 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

1998 593 citations M Rinaldi-Carmona, Francis Barth et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Portier France	9	655	449	446	268	239	13	1.3k
Pingwei Zhao China	22	436 0.7×	426 0.9×	527 1.2×	53 0.2×	178 0.7×	58	1.8k
Toshiya Ogorochi Japan	15	229 0.3×	138 0.3×	395 0.9×	75 0.3×	220 0.9×	15	1.2k
Nariman Balenga United States	17	770 1.2×	475 1.1×	594 1.3×	24 0.1×	67 0.3×	28	1.5k
Dean Spurden United Kingdom	18	192 0.3×	288 0.6×	564 1.3×	131 0.5×	67 0.3×	33	1.0k
Alexandra Moers Germany	15	97 0.1×	161 0.4×	482 1.1×	243 0.9×	86 0.4×	17	1.1k
Daniel Rueda Spain	18	1.1k 1.8×	726 1.6×	463 1.0×	13 0.0×	370 1.5×	49	2.0k
Marie‐Claude Mathieu Canada	16	223 0.3×	108 0.2×	184 0.4×	66 0.2×	90 0.4×	21	748
Daniel R. Premkumar United States	27	111 0.2×	152 0.3×	956 2.1×	30 0.1×	195 0.8×	44	1.9k
Tsunehisa Namba Japan	17	769 1.2×	489 1.1×	828 1.9×	26 0.1×	85 0.4×	27	1.7k
Fariborz Rakhshan United States	8	330 0.5×	293 0.7×	428 1.0×	23 0.1×	37 0.2×	11	846

Countries citing papers authored by M Portier

Since Specialization

Citations

This map shows the geographic impact of M Portier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Portier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Portier more than expected).

Fields of papers citing papers by M Portier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Portier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Portier. The network helps show where M Portier may publish in the future.

Co-authorship network of co-authors of M Portier

This figure shows the co-authorship network connecting the top 25 collaborators of M Portier. A scholar is included among the top collaborators of M Portier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Portier. M Portier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Johnson, Lacey, et al.. (2025). Preparation of cold‐stored platelets on‐demand: A novel approach to inventory management. Transfusion. 65(10). 1903–1913. 1 indexed citations

2.

Heestermans, Marco, Charles‐Antoine Arthaud, Marie‐Ange Eyraud, et al.. (2024). In platelet single donor apheresis, platelet factor 4 levels correlated with donor’s age and decreased during storage. Scientific Reports. 14(1). 3 indexed citations

3.

Stoebner, P, P Carayon, Pierre Casellas, et al.. (2001). Transient protection by peripheral benzodiazepine receptors during the early events of ultraviolet light-induced apoptosis. Cell Death and Differentiation. 8(7). 747–753. 47 indexed citations

4.

Portier, M, M Rinaldi-Carmona, Florence Pecceu, et al.. (1999). SR 144528, an Antagonist for the Peripheral Cannabinoid Receptor that Behaves as an Inverse Agonist. Journal of Pharmacology and Experimental Therapeutics. 288(2). 582–589. 89 indexed citations

5.

Ovigne, J.‐M., Claudine Vermot‐Desroches, Jean‐Claude Lecron, et al.. (1998). An antagonistic monoclonal antibody (B-N6) specific for the human neurotensin receptor-1. Neuropeptides. 32(3). 247–256. 5 indexed citations

6.

Rinaldi-Carmona, M, Francis Barth, Jean‐Marie Derocq, et al.. (1998). SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor. Journal of Pharmacology and Experimental Therapeutics. 284(2). 644–650. 593 indexed citations breakdown →

7.

Carayon, P, M Portier, D. Dussossoy, et al.. (1996). Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. Blood. 87(8). 3170–3178. 158 indexed citations

8.

Portier, M, XG Zhang, Émilie Caron, et al.. (1993). gamma-Interferon in multiple myeloma: inhibition of interleukin-6 (IL- 6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro. Blood. 81(11). 3076–3082. 69 indexed citations

9.

Portier, M, XG Zhang, Émilie Caron, et al.. (1993). gamma-Interferon in multiple myeloma: inhibition of interleukin-6 (IL- 6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro. Blood. 81(11). 3076–3082. 3 indexed citations

10.

Portier, M, Jean‐Pierre Molès, P Jeanteur, et al.. (1992). p53 and RAS gene mutations in multiple myeloma.. PubMed. 7(12). 2539–43. 120 indexed citations

11.

Klein, Bernard, XG Zhang, M Jourdan, et al.. (1991). Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.. PubMed. 1(4). 193–201. 109 indexed citations

12.

Jourdan, M, et al.. (1991). IFN-alpha induces autocrine production of IL-6 in myeloma cell lines. The Journal of Immunology. 147(12). 4402–4407. 86 indexed citations

13.

Klein, Bernard, et al.. (1990). Interleukin-6 is a Major Myeloma Cell Growth Factor In Vitro and In Vivo Especially in Patients with Terminal Disease. Current topics in microbiology and immunology. 166. 23–31. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact